A study published in the journal Science Advances details a promising, new avenue toward improving awake brain mapping results by investigating the tiny, nearly imperceptible variabilities in patient ...

Brainlab SE (Brainlab), a digital medical technology company automating and optimizing clinical workflows using artificial intelligence and sophisticated software algorithms, and Precision NeuroMed ...

Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent ...

Beyond these more general symptoms, there are some neurological signs that are typical of brain tumors. According to Dr. Ramakrishna and Dr. Sivakumar, these may include: “Symptoms often develop ...

The new Category III CPT code will be published on July 1, 2026 and will become effective for reporting on January 1, 2027.

The Royal Hobart Hospital Research Foundation is pumping more than $310,000 into four new medical research projects this year ...

This patient disease education initiative and award highlights exceptional people who have inspired others through ...

Scarsdale10583 is the #1 Community Website for Scarsdale, New York offering community news, local events, people, schools, real estate and more.

Siren recently announced FDA clearance of its first Investigational New Drug (IND) filing for SRN-101, enabling first-in-human clinical evaluation in patients with recurrent high-grade glioma. SRN-101 ...

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application from FluoGuide A/S in Copenhagen, Denmark, allowing the company to move forward in the U.S. with a ...

Our goal is to provide the highest level of expertise and to treat every patient with the same intensity and care we ...